Single Use Bioreactors Market

Single Use Bioreactors Market by Product (System, Media Bag, Filtration assemblies), Type (Stirred tank, Bubble column), Cell Type (Mammalian, Bacterial, Yeast), Molecule (mAbs, Vaccines), End User (Pharma, Biotech, CROs, CMOs) & Region - Global Forecast to 2028

Report Code: BT 2863 Mar, 2023, by marketsandmarkets.com

Single Use Bioreactors Market Size & Trends

The global single use bioreactors market in terms of revenue was estimated to be worth $4.2 billion in 2023 and is poised to reach $10.0 billion by 2028, growing at a CAGR of 19.0% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Startups and SMEs have been increasingly adopting Single use bioreactors due to the advantages they offer over conventional single use bioreactor systems, the reduced operational complexity offered by single use bioreactors, the growing market for biologic and biosimilar drugs and availability of technologically advanced single use bioreactors are factors attracting larger customer base for the players operating in this market. However, the extractable and leachable have been an issue of concern which is likely to restrict the market growth to certain extent.

Attractive Opportunities in the Single Use Bioreactors Market

Single use Bioreactors Market

To know about the assumptions considered for the study, Request for Free Sample Report

Single Use Bioreactors Market Dynamics

Driver: Increasing adoption of single use bioreactors among startups and SMEs

Biomanufacturing facility set up demands huge capital investments. For emerging pharmaceutical, biopharmaceutical, biotechnology companies, biomanufacturing involves less than five batches or campaigns per year. For this scale, setting up of stainless-steel facility can be capital intensive. However, on the other side, manufacturing facilities with single use systems are less capital intensive as cleaning processes, sterilization, changeover and validation procedures steps are not required in such facilities. Therefore, startups and SMEs save on costs by adopting single use systems and associated products. Moreover, the flexibility in scaling up offered by single use bioreactors is also attracting these companies as top global players offer a broad range of bioreactor volumes with accessories.

Restraint: Issues related to leachables and extractables

Extractables and leachables have been an issue in single use bioprocessing in the past for more than a decade now. As single use bioreactors are primarily made of polymer layers welded together in which each of the layers adds to the physical or chemical properties required for the single use bioreactor to function as a bioreactor properly. These polymer layers may have their particular set of additives like antioxidants, fillers, plasticizers, and stabilizers, among others, to obtain the necessary characteristics. These leach out of the layers into the drug substance bioprocessed in the single use bioreactor bags. Moreover, there are no well-established regulations in use of these polymers. Thus, this factor is likely to restrain the market growth to certain extent.

Opportunity: Hybrid facilities for sustainable manufacturing

Hybrid approach includes manufacturing some components of the process using single use technologies, while others using traditional reusable, permanently plumbed systems. Cost and time pressures on the pharmaceutical industry are ever-growing. Currently, in order to react to new developments in the sector as quickly as possible, the focus is increasingly centered on time-to-market as well as modular, highly flexible production concepts for new biopharmaceutical products. The key advantages offered by hybrid facilities include lower costs, smaller footprints, and less support infrastructure, with some reusable equipment. Thus, an overall decrease in capital investment and increased flexibility associated with single use systems are resulting in their increased use by CDMOs as well as their clients.

Challenge: Disposal of waste

single use bioreactors are stainless-steel bodies lined with bioreactor bags, assemblies, and other accessories for applications such as bioproduction, process development, and research & development. These bags and assemblies are disposed-off after a single use. This creates large amounts of plastic waste after every cycle of production. Biopharmaceutical companies are increasingly adopting single use bioprocessing systems considering the several benefits offered by them, such as cost reduction, faster process development time, and lower capital investments, but there are serious concerns related to the waste disposal from this alternative technology. Many single use suppliers are actively pursuing the development or implementation of more sustainable options for manufacturers. Currently, most used materials from single use manufacturing are decontaminated and commercially landfilled or incinerated. But there is an opportunity to further reduce the unfavorable impact of single use systems through incineration with energy recovery or other more sustainable waste streams. These include landfill (untreated, treated, or with grinding), recycling, incineration (with and without energy recovery), and pyrolysis.

The market ecosystem comprises raw material suppliers, manufacturers, and end users such as pharmaceutical & biotech companies, academic and research institutes, and CROS & CMOs.

The prominent single use bioreactor product providers are Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Getinge AB (Sweden), Eppendorf AG (Germany), Entegris, Inc. (US) and Avantor, Inc. (US).

Single Use Bioreactors Market Ecosystem Analysis

single use Bioreactors Market Ecosystem

Source: Annual Reports, SEC Filings, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis

Based on product, single use bioreactor systems segment accounted for the largest market share of the single use bioreactors industry

Based on product, the single use bioreactors market is segmented into single use bioreactor systems, single use media bags, single use filtration assemblies, and other products. The single use bioreactor systems segment held the largest share in 2022 owing to the advantages that it offers such as lower capital investment, lower operating expenses, and lower environmental footprint.

Based on drug type, stirred-tank single use bioreactors segment accounted for the largest market share of the single use bioreactors industry

Based on drug type, the single use bioreactors market is segmented into stirred-tank single use bioreactors, wave-induced single use bioreactors, bubble-column single use bioreactors, and other single use bioreactors (hybrid bioreactors, single use bioreactors with vertically perforated discs). The stirred-tank single use bioreactors segment held the largest share in 2022, owing to the high preference for stirred-tank single use bioreactors in the bioproduction of aerobic microbial cell cultures.

Based on the type of molecule, monoclonal antibodies (mAbs) segment accounted for the largest market share of the single use bioreactors industry

Based on the type of molecule, the single use bioreactors market is segmented into monoclonal antibodies (mAbs), vaccines, gene-modified cells, stem cells, and other molecules. In 2022, the monoclonal antibodies segment accounted for the largest share owing to factors such as the increasing demand for single use bioreactors in the manufacturing of mAbs, low investment costs and less time-consuming changeover procedures.

The North American market is projected to contribute the largest share for the single use bioreactors industry.

The global market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional market for single use bioreactors, while Europe is the second-largest market. A well-established pharmaceutical, biotechnology industries and the presence of major players operating in the single use bioreactors in the region are driving the market growth. North America is the largest pharmaceutical market in the world, with many global pharmaceutical and biopharmaceutical giants headquartered in the region, such as Danaher Corporation (US) and Thermo Fisher Scientific (US).

Single Use Bioreactors Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The single use bioreactors market is dominated by a few globally established players such as Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), and Merck KGaA (Germany), among others, are the key product providers that provided market products in last few years. Major focus was given to the product launches, collaborations, agreements, acquisitions, and partnerships due to the changing requirements of pharmaceutical and biopharmaceutical companies, academic and research institutes, and CROs & CMOs across the world.

Scope of the Single Use Bioreactors Industry

Report Metric

Details

Market Revenue in 2023

$4.2 billion

Projected Revenue by 2028

$10 billion

Revenue Rate

Poised to grow at a CAGR of 19.0%

Market Driver

Increasing adoption of single use bioreactors among startups and SMEs

Market Opportunity

Hybrid facilities for sustainable manufacturing

This report categorizes the single use bioreactors market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • single use bioreactor systems
  • Up to 10 L
  • 11–100 L
  • 101–500 L
  • 501–1500 L
  • Above 1500 L
  • single use media bags
  • 2D Bags
  • 3D Bags
  • Other bags
  • single use filtration assemblies
  • Other products

By Type of Molecule

  • Stirred-tank single use bioreactors
  • Wave-induced single use bioreactors
  • Bubble-column single use bioreactors
  • Other single use bioreactors

By Type of Cell

  • Mammalian cells
  • Bacterial cells
  • Yeast cells
  • Other cells

By Application

  • Bioproduction
  • Process development
  • Research & development

By End User

  • Pharmaceutical & biotechnology companies
  • CROs & CMOs
  • Academic & research institutes

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • South Korea
    • Japan
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America (LATAM)
    • Brazil
    • RoLATAM
  • Middle East and Africa (MEA)

Recent Developments of Single Use Bioreactors Industry

  • In November 2022, Sartorius GA (Germany) planned to invest in growing its operations by establishing new R&D laboratories and digitalizing & automating equipment, among other approaches. This development was aimed at meeting the high demand from the biopharmaceutical industry.
  • In November 2022, Danaher Corporation (US) subsidiary, Cytiva invested around USD 8 million to expand its Fast Trak center in Shanghai, China. The single use Technologies (SUT) center of excellence in Asia offers new product R&D tests and validation with an aim to facilitate the industry’s application of SUT throughout the region.
  • In August 2022, Thermo Fisher Scientific (US) opened its largest single use technology manufacturing site in Greater Nashville with an investment of USD 105 million to meet the growing demand for the bioprocessing materials needed to produce vaccines and breakthrough therapies for cancer and other diseases.   

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 48)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
          FIGURE 1 SINGLE USE BIOREACTORS MARKET SEGMENTATION
           1.3.1 YEARS CONSIDERED
    1.4 CURRENCY 
    1.5 LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
           1.7.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 54)
    2.1 RESEARCH DATA 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 3 SINGLE USE BIOREACTORS MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
          FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 6 ILLUSTRATIVE EXAMPLE OF SARTORIUS AG: REVENUE SHARE ANALYSIS (2022)
           2.2.1 INSIGHTS FROM PRIMARIES
                    FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
                    FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 GROWTH FORECAST 
          FIGURE 9 MARKET: CAGR PROJECTIONS
          FIGURE 10 MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 11 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 RECESSION IMPACT ON MARKET 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
 
3 EXECUTIVE SUMMARY (Page No. - 66)
    FIGURE 12 SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 MARKET, BY TYPE OF MOLECULE, 2023 VS. 2028 (USD MILLION)
    FIGURE 15 MARKET, BY TYPE OF CELL, 2023 VS. 2028 (USD MILLION)
    FIGURE 16 MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 17 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 18 GEOGRAPHICAL SNAPSHOT OF SINGLE USE BIOREACTORS INDUSTRY
 
4 PREMIUM INSIGHTS (Page No. - 72)
    4.1 SINGLE USE BIOREACTORS MARKET OVERVIEW 
          FIGURE 19 GROWING BIOPHARMACEUTICAL INDUSTRY TO DRIVE MARKET
    4.2 NORTH AMERICA: MARKET SHARE, BY TYPE OF MOLECULE AND COUNTRY (2022) 
          FIGURE 20 MONOCLONAL ANTIBODIES SEGMENT DOMINATED NORTH AMERICAN MARKET IN 2022
    4.3 MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 
          FIGURE 21 SINGLE USE BIOREACTOR SYSTEMS TO CONTINUE TO DOMINATE MARKET IN 2028
    4.4 MARKET SHARE, BY END USER (2022) 
          FIGURE 22 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
    4.5 SINGLE USE BIOREACTORS INDUSTRY: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 23 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE IN MARKET FROM 2023 TO 2028
 
5 MARKET OVERVIEW (Page No. - 76)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 24 SINGLE USE BIOREACTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 2 MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing adoption of SINGLE USE bioreactors among startups and SMEs
                    5.2.1.2 Reduced operational complexity of SINGLE USE bioreactors compared to conventional bioreactors
                    5.2.1.3 Lower energy and water consumption
                    5.2.1.4 Growing biologics and biosimilars market
                    5.2.1.5 Technological advancements in SINGLE USE bioreactors
           5.2.2 RESTRAINTS
                    5.2.2.1 Regulatory concerns related to SINGLE USE bioreactors
                    5.2.2.2 Issues related to leachables and extractables
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Hybrid facilities for sustainable manufacturing
                    5.2.3.2 Emerging markets
           5.2.4 CHALLENGES
                    5.2.4.1 Standardization of SINGLE USE designs
                    5.2.4.2 Disposal of waste
    5.3 INDUSTRY TRENDS 
           5.3.1 INCREASING FOCUS ON SINGLE USE BIOPROCESSING CAPACITIES AND TECHNOLOGICAL COMPETITIVENESS
                    TABLE 3 SINGLE USE BIOREACTOR CAPACITY EXPANSIONS BY MAJOR PLAYERS
           5.3.2 INCREASING ADOPTION OF SINGLE USE SYSTEMS BY CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS
           5.3.3 AUTOMATION IN SINGLE USE BIOREACTORS
    5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 
          FIGURE 25 REVENUE SHIFT AND NEW POCKETS FOR SINGLE USE BIOREACTOR PROVIDERS
    5.5 PRICING ANALYSIS 
    5.6 VALUE CHAIN ANALYSIS 
          FIGURE 26 VALUE CHAIN ANALYSIS OF SINGLE USE BIOREACTORS: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE
    5.7 SUPPLY CHAIN ANALYSIS 
          FIGURE 27 MARKET: SUPPLY CHAIN ANALYSIS
          TABLE 4 OVERALL SUPPLY CHAIN ECOSYSTEM FOR SINGLE USE BIOREACTORS
    5.8 ECOSYSTEM ANALYSIS 
          FIGURE 28 SINGLE USE BIOREACTORS INDUSTRY: ECOSYSTEM ANALYSIS
    5.9 TECHNOLOGY ANALYSIS 
           5.9.1 WAVE-INDUCED MOTION TECHNOLOGY
           5.9.2 BUBBLE-COLUMN TECHNOLOGY
           5.9.3 STIRRED-TANK TECHNOLOGY
           5.9.4 VERTICALLY PERFORATED DISCS
    5.10 PATENT ANALYSIS 
           FIGURE 29 PATENT APPLICATIONS FOR MARKET, JANUARY 2012–FEBRUARY 2023
           TABLE 5 INDICATIVE LIST OF PATENTS IN MARKET
    5.11 KEY CONFERENCES AND EVENTS DURING 2023–2024 
           TABLE 6 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    5.12 REGULATORY ANALYSIS 
           5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.13 PORTER’S FIVE FORCES ANALYSIS 
           TABLE 11 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.13.1 THREAT OF NEW ENTRANTS
           5.13.2 THREAT OF SUBSTITUTES
           5.13.3 BARGAINING POWER OF SUPPLIERS
           5.13.4 BARGAINING POWER OF BUYERS
           5.13.5 INTENSITY OF COMPETITIVE RIVALRY
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE USE BIOREACTOR PRODUCTS
           5.14.2 BUYING CRITERIA FOR SINGLE USE BIOREACTORS
                     FIGURE 31 KEY BUYING CRITERIA FOR END USERS
 
6 SINGLE USE BIOREACTORS MARKET, BY PRODUCT (Page No. - 100)
    6.1 INTRODUCTION 
          TABLE 12 SINGLE USE BIOREACTORS INDUSTRY, BY PRODUCT, 2021–2028 (USD MILLION)
    6.2 SINGLE USE BIOREACTOR SYSTEMS 
           6.2.1 ADVANTAGES OFFERED OVER CONVENTIONAL BIOREACTORS TO DRIVE ADOPTION
                    TABLE 13 EXAMPLES OF SINGLE USE BIOREACTOR SYSTEMS OFFERED BY MARKET PLAYERS
                    TABLE 14 SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                    TABLE 15 SINGLE USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 16 NORTH AMERICA: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 17 EUROPE: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 18 ASIA PACIFIC: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 19 LATIN AMERICA: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.2 UP TO 10 L
                    TABLE 20 UP TO 10 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 21 NORTH AMERICA: UP TO 10 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 22 EUROPE: UP TO 10 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 23 ASIA PACIFIC: UP TO 10 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 24 LATIN AMERICA: UP TO 10 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.3 11–100 L
                    TABLE 25 11 TO 100 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 26 NORTH AMERICA: 11 TO 100 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 27 EUROPE: 11 TO 100 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 28 ASIA PACIFIC: 11 TO 100 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 29 LATIN AMERICA: 11 TO 100 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.4 101–500 L
                    TABLE 30 101 TO 500 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 31 NORTH AMERICA: 101 TO 500 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 32 EUROPE: 101 TO 500 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 33 ASIA PACIFIC: 101 TO 500 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 34 LATIN AMERICA: 101 TO 500 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.5 501–1,500 L
                    TABLE 35 501 TO 1,500 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 36 NORTH AMERICA: 501 TO 1,500 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 37 EUROPE: 501 TO 1,500 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 38 ASIA PACIFIC: 501 TO 1,500 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 39 LATIN AMERICA: 501 TO 1,500 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.6 ABOVE 1,500 L
                    TABLE 40 ABOVE 1,500 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 41 NORTH AMERICA: ABOVE 1,500 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 42 EUROPE: ABOVE 1,500 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 43 ASIA PACIFIC: ABOVE 1,500 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 44 LATIN AMERICA: ABOVE 1,500 L SINGLE USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 SINGLE USE MEDIA BAGS 
           6.3.1 MAINLY USED IN BUFFER AND MEDIA STORAGE
                    TABLE 45 SINGLE USE MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 46 SINGLE USE MEDIA BAGS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 47 NORTH AMERICA: SINGLE USE MEDIA BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 48 EUROPE: SINGLE USE MEDIA BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 49 ASIA PACIFIC: SINGLE USE MEDIA BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 50 LATIN AMERICA: SINGLE USE MEDIA BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.2 2D BAGS
                    TABLE 51 2D BAGS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 52 NORTH AMERICA: 2D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 53 EUROPE: 2D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 54 ASIA PACIFIC: 2D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 55 LATIN AMERICA: 2D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.3 3D BAGS
                    TABLE 56 3D BAGS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 57 NORTH AMERICA: 3D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 58 EUROPE: 3D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 59 ASIA PACIFIC: 3D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 60 LATIN AMERICA: 3D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.4 OTHER BAGS
                    TABLE 61 OTHER BAGS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 62 NORTH AMERICA: OTHER BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 63 EUROPE: OTHER BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 64 ASIA PACIFIC: OTHER BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 65 LATIN AMERICA: OTHER BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.4 SINGLE USE FILTRATION ASSEMBLIES 
           6.4.1 REDUCED RISK OF CONTAMINATION TO PROPEL DEMAND FOR SINGLE USE FILTRATION ASSEMBLIES
                    TABLE 66 SINGLE USE FILTRATION ASSEMBLIES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 67 NORTH AMERICA: SINGLE USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 68 EUROPE: SINGLE USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 69 ASIA PACIFIC: SINGLE USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 70 LATIN AMERICA: SINGLE USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.5 OTHER PRODUCTS 
          TABLE 71 OTHER SINGLE USE BIOREACTOR PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 72 NORTH AMERICA: OTHER SINGLE USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 73 EUROPE: OTHER SINGLE USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 74 ASIA PACIFIC: OTHER SINGLE USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 75 LATIN AMERICA: OTHER SINGLE USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 SINGLE USE BIOREACTORS MARKET, BY TYPE (Page No. - 131)
    7.1 INTRODUCTION 
          TABLE 76 SINGLE USE BIOREACTORS INDUSTRY, BY TYPE, 2021–2028 (USD MILLION)
    7.2 STIRRED-TANK SINGLE USE BIOREACTORS 
           7.2.1 PREFERRED FOR AEROBIC MICROBIAL CELL CULTURES
                    TABLE 77 EXAMPLES OF STIRRED-TANK SINGLE USE BIOREACTORS OFFERED BY MARKET PLAYERS
                    TABLE 78 MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 79 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 80 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 81 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 82 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 WAVE-INDUCED SINGLE USE BIOREACTORS 
           7.3.1 BEST SUITED FOR SHEAR STRESS-SENSITIVE CELL LINES
                    TABLE 83 MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 84 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 85 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 86 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 87 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.4 BUBBLE-COLUMN SINGLE USE BIOREACTORS 
           7.4.1 EFFICIENT MASS AND HEAT TRANSFER CAPABILITY TO DRIVE GROWTH
                    TABLE 88 MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 89 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 90 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 91 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 92 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.5 OTHER SINGLE USE BIOREACTORS 
          TABLE 93 MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 94 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 95 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 96 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 97 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 SINGLE USE BIOREACTORS MARKET, BY TYPE OF MOLECULE (Page No. - 144)
    8.1 INTRODUCTION 
          TABLE 98 SINGLE USE BIOREACTORS INDUSTRY, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
    8.2 MONOCLONAL ANTIBODIES 
           8.2.1 GROWING THERAPEUTIC APPLICATIONS TO DRIVE DEMAND FOR SINGLE USE BIOREACTORS IN R&D AND MANUFACTURING APPLICATIONS
                    TABLE 99 MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 100 NORTH AMERICA: MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 101 EUROPE: MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 102 ASIA PACIFIC: MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 103 LATIN AMERICA: MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 VACCINES 
           8.3.1 USE OF SINGLE USE SYSTEMS FOR VACCINE PRODUCTION TO INCREASE PRODUCTION CAPACITIES WITH REDUCED COST
                    TABLE 104 MARKET FOR VACCINES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 105 NORTH AMERICA: MARKET FOR VACCINES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 106 EUROPE: MARKET FOR VACCINES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 107 ASIA PACIFIC: MARKET FOR VACCINES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 108 LATIN AMERICA: MARKET FOR VACCINES, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 STEM CELLS 
           8.4.1 GROWING RESEARCH AND COMMERCIALIZATION OF STEM CELL THERAPIES TO DRIVE MARKET
                    TABLE 109 MARKET FOR STEM CELLS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 110 NORTH AMERICA: MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 111 EUROPE: MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 112 ASIA PACIFIC: MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 113 LATIN AMERICA: MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.5 GENE-MODIFIED CELLS 
           8.5.1 GROWING MARKET FOR GENE AND CELL THERAPIES TO DRIVE MARKET
                    TABLE 114 MARKET FOR GENE-MODIFIED CELLS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 115 NORTH AMERICA: MARKET FOR GENE-MODIFIED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 116 EUROPE: MARKET FOR GENE-MODIFIED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 117 ASIA PACIFIC: MARKET FOR GENE-MODIFIED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 118 LATIN AMERICA: MARKET FOR GENE-MODIFIED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.6 OTHER MOLECULES 
          TABLE 119 MARKET FOR OTHER MOLECULES, BY REGION, 2021–2028 (USD MILLION)
          TABLE 120 NORTH AMERICA: MARKET FOR OTHER MOLECULES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 121 EUROPE: MARKET FOR OTHER MOLECULES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 122 ASIA PACIFIC: MARKET FOR OTHER MOLECULES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 123 LATIN AMERICA: MARKET FOR OTHER MOLECULES, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 SINGLE USE BIOREACTORS MARKET, BY TYPE OF CELL (Page No. - 160)
    9.1 INTRODUCTION 
          TABLE 124 SINGLE USE BIOREACTORS INDUSTRY, BY TYPE OF CELL, 2021–2028 (USD MILLION)
    9.2 MAMMALIAN CELLS 
           9.2.1 USED IN PRODUCTION OF MONOCLONAL ANTIBODIES AND THERAPEUTIC PROTEINS
                    TABLE 125 MARKET FOR MAMMALIAN CELLS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 126 NORTH AMERICA: MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 127 EUROPE: MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 128 ASIA PACIFIC: MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 129 LATIN AMERICA: MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 BACTERIAL CELLS 
           9.3.1 GROWING ADOPTION IN COMMERCIAL VACCINES AND RECOMBINANT PROTEIN PRODUCTION TO DRIVE MARKET
                    TABLE 130 MARKET FOR BACTERIAL CELLS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 131 NORTH AMERICA: MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 132 EUROPE: MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 133 ASIA PACIFIC: MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 134 LATIN AMERICA: MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
    9.4 YEAST CELLS 
           9.4.1 FASTER GROWTH RATE AND MINIMAL MEDIA CONDITIONS TO DRIVE ADOPTION IN RECOMBINANT PROTEIN PRODUCTION
                    TABLE 135 MARKET FOR YEAST CELLS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 136 NORTH AMERICA: MARKET FOR YEAST CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 137 EUROPE: MARKET FOR YEAST CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 138 ASIA PACIFIC: MARKET FOR YEAST CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 139 LATIN AMERICA: MARKET FOR YEAST CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
    9.5 OTHER CELLS 
          TABLE 140 MARKET FOR OTHER CELLS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 141 NORTH AMERICA: MARKET FOR OTHER CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 142 EUROPE: MARKET FOR OTHER CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 143 ASIA PACIFIC: MARKET FOR OTHER CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 144 LATIN AMERICA: MARKET FOR OTHER CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
 
10 SINGLE USE BIOREACTORS MARKET, BY APPLICATION (Page No. - 171)
     10.1 INTRODUCTION 
             TABLE 145 SINGLE USE BIOREACTORS INDUSTRY, BY APPLICATION, 2021–2028 (USD MILLION)
     10.2 BIOPRODUCTION 
             10.2.1 INCREASING BIOPHARMACEUTICAL PRODUCTION TO DRIVE DEMAND FOR COST-EFFECTIVE SINGLE USE BIOREACTORS
                        TABLE 146 MARKET FOR BIOPRODUCTION, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 147 NORTH AMERICA: MARKET FOR BIOPRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 148 EUROPE: MARKET FOR BIOPRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 149 ASIA PACIFIC: MARKET FOR BIOPRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 150 LATIN AMERICA: MARKET FOR BIOPRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
     10.3 PROCESS DEVELOPMENT 
             10.3.1 LOW CROSS-CONTAMINATION RISK AND OPERATIONAL FLEXIBILITY TO DRIVE MARKET
                        TABLE 151 MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 152 NORTH AMERICA: MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 153 EUROPE: MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 154 ASIA PACIFIC: MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 155 LATIN AMERICA: MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
     10.4 RESEARCH AND DEVELOPMENT 
             10.4.1 SINGLE USE BIOREACTORS INCREASINGLY ADOPTED FOR R&D APPLICATIONS DUE TO COST-EFFECTIVENESS
                        TABLE 156 MARKET FOR RESEARCH AND DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 157 NORTH AMERICA: MARKET RESEARCH AND DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 158 EUROPE: MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 159 ASIA PACIFIC: MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 160 LATIN AMERICA: MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
 
11 SINGLE USE BIOREACTORS MARKET, BY END USER (Page No. - 181)
     11.1 INTRODUCTION 
             TABLE 161 SINGLE USE BIOREACTORS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
     11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
             11.2.1 GROWING BIOLOGICS AND BIOSIMILARS MARKET TO INCREASE DEMAND FOR SINGLE USE BIOREACTORS
                        TABLE 162 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 163 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 164 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 165 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 166 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
     11.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS 
             11.3.1 INCREASING OUTSOURCING OF R&D AND MANUFACTURING SERVICES BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO SUPPORT MARKET GROWTH
                        TABLE 167 MARKET FOR CROS & CMOS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 168 NORTH AMERICA: MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 169 EUROPE: MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 170 ASIA PACIFIC: MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 171 LATIN AMERICA: MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2028 (USD MILLION)
     11.4 ACADEMIC & RESEARCH INSTITUTES 
             11.4.1 GROWING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO DRIVE MARKET
                        TABLE 172 MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 173 NORTH AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 174 EUROPE: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 175 ASIA PACIFIC: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 176 LATIN AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
 
12 SINGLE USE BIOREACTORS MARKET, BY REGION (Page No. - 191)
     12.1 INTRODUCTION 
             TABLE 177 SINGLE USE BIOREACTORS INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
     12.2 NORTH AMERICA 
             FIGURE 32 NORTH AMERICA: SINGLE USE BIOREACTORS MARKET SNAPSHOT
             TABLE 178 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 179 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 180 NORTH AMERICA: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
             TABLE 181 NORTH AMERICA: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 182 NORTH AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 183 NORTH AMERICA: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
             TABLE 184 NORTH AMERICA: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
             TABLE 185 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 186 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.2.1 US
                        12.2.1.1 US to dominate single use bioreactors market in North America
                                      TABLE 187 US: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 188 US: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                                      TABLE 189 US: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 190 US: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 191 US: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                                      TABLE 192 US: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                                      TABLE 193 US: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 194 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.2.2 CANADA
                        12.2.2.1 Increasing focus of biopharmaceutical companies on enhancing manufacturing capacity to support market growth
                                      TABLE 195 CANADA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 196 CANADA: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                                      TABLE 197 CANADA: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 198 CANADA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 199 CANADA: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                                      TABLE 200 CANADA: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                                      TABLE 201 CANADA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 202 CANADA: SINGLE USE BIOREACTORS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             12.2.3 NORTH AMERICA: RECESSION IMPACT
     12.3 EUROPE 
             TABLE 203 EUROPE: SINGLE USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 204 EUROPE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 205 EUROPE: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
             TABLE 206 EUROPE: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 207 EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 208 EUROPE: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
             TABLE 209 EUROPE: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
             TABLE 210 EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 211 EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.1 GERMANY
                        12.3.1.1 Increasing adoption of SINGLE USE bioreactors by CDM0s and biopharma companies to propel market
                                      TABLE 212 GERMANY: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 213 GERMANY: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                                      TABLE 214 GERMANY: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 215 GERMANY: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 216 GERMANY: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                                      TABLE 217 GERMANY: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                                      TABLE 218 GERMANY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 219 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.2 UK
                        12.3.2.1 Government support to biotech companies to result in high adoption of SINGLE USE bioreactors
                                      TABLE 220 UK: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 221 UK: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                                      TABLE 222 UK: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 223 UK: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 224 UK: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                                      TABLE 225 UK: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                                      TABLE 226 UK: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 227 UK: MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.3 FRANCE
                        12.3.3.1 Growing investments by life sciences companies in research infrastructure projects to contribute to market growth
                                      TABLE 228 FRANCE: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 229 FRANCE: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                                      TABLE 230 FRANCE: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 231 FRANCE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 232 FRANCE: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                                      TABLE 233 FRANCE: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                                      TABLE 234 FRANCE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 235 FRANCE: SINGLE USE BIOREACTORS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             12.3.4 ITALY
                        12.3.4.1 Increasing investments in drug discovery and SINGLE USE system development to boost market
                                      TABLE 236 ITALY: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 237 ITALY: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                                      TABLE 238 ITALY: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 239 ITALY: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 240 ITALY: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                                      TABLE 241 ITALY: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                                      TABLE 242 ITALY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 243 ITALY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.5 SPAIN
                        12.3.5.1 Rising use of SINGLE USE bioprocessing technologies to foster market growth
                                      TABLE 244 SPAIN: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 245 SPAIN: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                                      TABLE 246 SPAIN: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 247 SPAIN: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 248 SPAIN: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                                      TABLE 249 SPAIN: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                                      TABLE 250 SPAIN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 251 SPAIN: MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.6 REST OF EUROPE
                        TABLE 252 REST OF EUROPE: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 253 REST OF EUROPE: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                        TABLE 254 REST OF EUROPE: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 255 REST OF EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 256 REST OF EUROPE: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                        TABLE 257 REST OF EUROPE: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                        TABLE 258 REST OF EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 259 REST OF EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.7 EUROPE: RECESSION IMPACT
     12.4 ASIA PACIFIC 
             FIGURE 33 ASIA PACIFIC: SINGLE USE BIOREACTORS MARKET SNAPSHOTS
             TABLE 260 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 261 ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 262 ASIA PACIFIC: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY RANGE SCALE, 2021–2028 (USD MILLION)
             TABLE 263 ASIA PACIFIC: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 264 ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 265 ASIA PACIFIC: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
             TABLE 266 ASIA PACIFIC: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
             TABLE 267 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 268 ASIA PACIFIC: SINGLE USE BIOREACTORS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             12.4.1 CHINA
                        12.4.1.1 Land leasing and subsidy initiatives of government for biopharma companies and CMOs to contribute to market growth
                                      TABLE 269 CHINA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 270 CHINA: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                                      TABLE 271 CHINA: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 272 CHINA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 273 CHINA: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                                      TABLE 274 CHINA: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                                      TABLE 275 CHINA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 276 CHINA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.4.2 SOUTH KOREA
                        12.4.2.1 Increasing use of SINGLE USE solutions in R&D and commercial manufacturing to fuel market growth
                                      TABLE 277 SOUTH KOREA: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 278 SOUTH KOREA: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                                      TABLE 279 SOUTH KOREA: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 280 SOUTH KOREA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 281 SOUTH KOREA: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                                      TABLE 282 SOUTH KOREA: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                                      TABLE 283 SOUTH KOREA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 284 SOUTH KOREA: SINGLE USE BIOREACTORS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             12.4.3 JAPAN
                        12.4.3.1 Growing geriatric population and rising use of regenerative medicines to stimulate market growth
                                      TABLE 285 JAPAN: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 286 JAPAN: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                                      TABLE 287 JAPAN: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 288 JAPAN: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 289 JAPAN: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                                      TABLE 290 JAPAN: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                                      TABLE 291 JAPAN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 292 JAPAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.4.4 INDIA
                        12.4.4.1 Thriving pharma and biotech industries to create significant demand for SINGLE USE bioreactors
                                      TABLE 293 INDIA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 294 INDIA: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                                      TABLE 295 INDIA: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 296 INDIA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 297 INDIA: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                                      TABLE 298 INDIA: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                                      TABLE 299 INDIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 300 INDIA: SINGLE USE BIOREACTORS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             12.4.5 REST OF ASIA PACIFIC
                        TABLE 301 REST OF ASIA PACIFIC: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 302 REST OF ASIA PACIFIC: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                        TABLE 303 REST OF ASIA PACIFIC: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 304 REST OF ASIA PACIFIC: SINGLE USE BIOREACTOR MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 305 REST OF ASIA PACIFIC: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                        TABLE 306 REST OF ASIA PACIFIC: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                        TABLE 307 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 308 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.4.6 ASIA PACIFIC: RECESSION IMPACT
     12.5 LATIN AMERICA 
             TABLE 309 LATIN AMERICA: SINGLE USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 310 LATIN AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 311 LATIN AMERICA: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
             TABLE 312 LATIN AMERICA: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 313 LATIN AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 314 LATIN AMERICA: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
             TABLE 315 LATIN AMERICA: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
             TABLE 316 LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 317 LATIN AMERICA: SINGLE USE BIOREACTORS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             12.5.1 BRAZIL
                        12.5.1.1 Increasing investments in biomanufacturing to support market growth
                                      TABLE 318 BRAZIL: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 319 BRAZIL: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                                      TABLE 320 BRAZIL: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 321 BRAZIL: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 322 BRAZIL: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                                      TABLE 323 BRAZIL: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                                      TABLE 324 BRAZIL: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 325 BRAZIL: MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.5.2 REST OF LATIN AMERICA
                        TABLE 326 REST OF LATIN AMERICA: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 327 REST OF LATIN AMERICA: SINGLE USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                        TABLE 328 REST OF LATIN AMERICA: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 329 REST OF LATIN AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 330 REST OF LATIN AMERICA: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                        TABLE 331 REST OF LATIN AMERICA: BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                        TABLE 332 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 333 REST OF LATIN AMERICA: SINGLE USE BIOREACTORS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             12.5.3 LATIN AMERICA: RECESSION IMPACT
     12.6 MIDDLE EAST & AFRICA 
             12.6.1 STRATEGIC COLLABORATIONS AND AGREEMENTS IN BIOMANUFACTURING FIELD TO BOOST DEMAND FOR SINGLE USE BIOREACTORS
                        TABLE 334 MIDDLE EAST & AFRICA: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 335 MIDDLE EAST & AFRICA: SINGLE USE BIOSYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION)
                        TABLE 336 MIDDLE EAST & AFRICA: SINGLE USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 337 MIDDLE EAST & AFRICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 338 MIDDLE EAST & AFRICA: MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION)
                        TABLE 339 MIDDLE EAST & AFRICA: MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION)
                        TABLE 340 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 341 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
 
13 COMPETITIVE LANDSCAPE (Page No. - 276)
     13.1 INTRODUCTION 
     13.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 34 SINGLE USE BIOREACTORS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
     13.3 REVENUE SHARE ANALYSIS 
             FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
     13.4 MARKET SHARE ANALYSIS 
             FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
             TABLE 342 SINGLE USE BIOREACTORS INDUSTRY: DEGREE OF COMPETITION
     13.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS 
             FIGURE 37 MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
             13.5.1 STARS
             13.5.2 EMERGING LEADERS
             13.5.3 PERVASIVE PLAYERS
             13.5.4 PARTICIPANTS
     13.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 
             13.6.1 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 343 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN MARKET
             13.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 344 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN MARKET
     13.7 COMPANY EVALUATION QUADRANT: STARTUPS/SMES 
             FIGURE 38 SINGLE USE BIOREACTORS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022
             13.7.1 PROGRESSIVE COMPANIES
             13.7.2 STARTING BLOCKS
             13.7.3 RESPONSIVE COMPANIES
             13.7.4 DYNAMIC COMPANIES
     13.8 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS 
             TABLE 345 SINGLE USE BIOREACTORS INDUSTRY: DETAILED LIST OF KEY STARTUP/SME PLAYERS
             TABLE 346 SINGLE USE BIOREACTORS INDUSTRY: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
     13.9 COMPETITIVE SCENARIO AND TRENDS 
             13.9.1 PRODUCT LAUNCHES
                        TABLE 347 MARKET: PRODUCT LAUNCHES, JANUARY 2020–FEBRUARY 2023
             13.9.2 DEALS
                        TABLE 348 MARKET: DEALS, JANUARY 2020–FEBRUARY 2023
             13.9.3 OTHER DEVELOPMENTS
                        TABLE 349 SINGLE USE BIOREACTORS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–FEBRUARY 2023
 
14 COMPANY PROFILES (Page No. - 295)
     14.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             14.1.1 SARTORIUS AG
                        TABLE 350 SARTORIUS AG: COMPANY OVERVIEW
                        FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2022)
                        TABLE 351 SARTORIUS AG: PRODUCT OFFERINGS
                        TABLE 352 SARTORIUS AG: PRODUCT LAUNCHES
                        TABLE 353 SARTORIUS AG: DEALS
                        TABLE 354 SARTORIUS AG: OTHER DEVELOPMENTS
             14.1.2 DANAHER CORPORATION
                        TABLE 355 DANAHER CORPORATION: COMPANY OVERVIEW
                        FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 356 DANAHER CORPORATION: PRODUCT OFFERINGS
                        TABLE 357 DANAHER CORPORATION: DEALS
                        TABLE 358 DANAHER CORPORATION: OTHER DEVELOPMENTS
             14.1.3 THERMO FISHER SCIENTIFIC INC.
                        TABLE 359 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
                        FIGURE 41 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022)
                        TABLE 360 THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS
                        TABLE 361 THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS
             14.1.4 MERCK KGAA
                        TABLE 362 MERCK KGAA: COMPANY OVERVIEW
                        FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2022)
                        TABLE 363 MERCK KGAA: PRODUCT OFFERINGS
                        TABLE 364 MERCK KGAA: DEALS
                        TABLE 365 MERCK KGAA: OTHER DEVELOPMENTS
             14.1.5 GETINGE AB
                        TABLE 366 GETINGE AB: COMPANY OVERVIEW
                        FIGURE 43 GETINGE AB: COMPANY SNAPSHOT (2022)
                        TABLE 367 GETINGE AB: PRODUCT OFFERINGS
                        TABLE 368 GETINGE AB: DEALS
                        TABLE 369 GETINGE AB: OTHER DEVELOPMENTS
             14.1.6 EPPENDORF AG
                        TABLE 370 EPPENDORF AG: COMPANY OVERVIEW
                        FIGURE 44 EPPENDORF AG: COMPANY SNAPSHOT (2021)
                        TABLE 371 EPPENDORF AG: PRODUCT OFFERINGS
                        TABLE 372 EPPENDORF AG: PRODUCT LAUNCHES
                        TABLE 373 EPPENDORF AG: OTHER DEVELOPMENTS
             14.1.7 ENTEGRIS, INC.
                        TABLE 374 ENTEGRIS, INC.: COMPANY OVERVIEW
                        FIGURE 45 ENTEGRIS, INC.: COMPANY SNAPSHOT (2022)
                        TABLE 375 ENTEGRIS, INC.: PRODUCT OFFERINGS
                        TABLE 376 ENTEGRIS, INC.: OTHER DEVELOPMENTS
             14.1.8 AVANTOR
                        TABLE 377 AVANTOR: COMPANY OVERVIEW
                        FIGURE 46 AVANTOR: COMPANY SNAPSHOT (2022)
                        TABLE 378 AVANTOR: PRODUCT OFFERINGS
                        TABLE 379 AVANTOR: DEALS
                        TABLE 380 AVANTOR: OTHER DEVELOPMENTS
             14.1.9 CORNING
                        TABLE 381 CORNING: COMPANY OVERVIEW
                        FIGURE 47 CORNING: COMPANY SNAPSHOT (2022)
                        TABLE 382 CORNING: PRODUCT OFFERINGS
             14.1.10 CESCO BIOENGINEERING CO., LTD.
                        TABLE 383 CESCO BIOENGINEERING CO., LTD.: COMPANY OVERVIEW
                        TABLE 384 CESCO BIOENGINEERING CO., LTD.: PRODUCT OFFERINGS
             14.1.11 KÜHNER AG
                        TABLE 385 KÜHNER AG: COMPANY OVERVIEW
                        TABLE 386 KÜHNER AG: PRODUCT OFFERINGS
                        TABLE 387 KÜHNER AG: DEALS
             14.1.12 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING
                        TABLE 388 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: COMPANY OVERVIEW
                        FIGURE 48 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: COMPANY SNAPSHOT (2022)
                        TABLE 389 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: DEALS
                        TABLE 390 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: OTHER DEVELOPMENTS
             14.1.13 PBS BIOTECH, INC.
                        TABLE 391 PBS BIOTECH, INC.: COMPANY OVERVIEW
                        TABLE 392 PBS BIOTECH, INC.: PRODUCT OFFERINGS
                        TABLE 393 PBS BIOTECH, INC.: OTHER DEVELOPMENTS
             14.1.14 SATAKE MULTIMIX CORPORATION
                        TABLE 394 SATAKE MULTIMIX CORPORATION: COMPANY OVERVIEW
                        TABLE 395 SATAKE MULTIMIX CORPORATION: PRODUCT OFFERINGS
             14.1.15 G&G TECHNOLOGIES, INC.
                        TABLE 396 G&G TECHNOLOGIES, INC.: COMPANY OVERVIEW
                        TABLE 397 G&G TECHNOLOGIES, INC.: PRODUCT OFFERINGS
             14.1.16 ABEC, INC.
                        TABLE 398 ABEC, INC.: COMPANY OVERVIEW
                        TABLE 399 ABEC, INC.: PRODUCT OFFERINGS
                        TABLE 400 ABEC, INC.: PRODUCT LAUNCHES
                        TABLE 401 ABEC, INC.: DEALS
                        TABLE 402 ABEC, INC.: OTHER DEVELOPMENTS
             14.1.17 BBI-BIOTECH GMBH
                        TABLE 403 BBI-BIOTECH GMBH: COMPANY OVERVIEW
                        TABLE 404 BBI-BIOTECH GMBH: PRODUCT OFFERINGS
             14.1.18 REPROCELL, INC.
                        TABLE 405 REPROCELL, INC.: COMPANY OVERVIEW
                        TABLE 406 REPROCELL, INC.: PRODUCT OFFERINGS
                        TABLE 407 REPROCELL, INC.: DEALS
             14.1.19 CELLEXUS
                        TABLE 408 CELLEXUS: COMPANY OVERVIEW
                        TABLE 409 CELLEXUS: PRODUCT OFFERINGS
                        TABLE 410 CELLEXUS: DEALS
             14.1.20 DISTEK, INC.
                        TABLE 411 DISTEK INC.: COMPANY OVERVIEW
                        TABLE 412 DISTEK, INC.: PRODUCT OFFERINGS
                        TABLE 413 DISTEK, INC.: PRODUCT LAUNCHES
     14.2 OTHER PLAYERS 
             14.2.1 OMNIBRX BIOTECHNOLOGIES
             14.2.2 NEW HORIZON BIOTECHNOLOGY INC.
             14.2.3 GPC BIO
             14.2.4 MEISSNER FILTRATION PRODUCTS INC.
             14.2.5 CELL CULTURE COMPANY, LLC
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
15 APPENDIX (Page No. - 358)
     15.1 DISCUSSION GUIDE 
     15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     15.3 CUSTOMIZATION OPTIONS 
     15.4 RELATED REPORTS 
     15.5 AUTHOR DETAILS 

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as World Health Organization (WHO), National Institutes of Health (NIH), World Bank, United States Food and Drug Administration (US FDA), US Census Bureau, National Institute for Bioprocessing Research and Training (NIBRT), Society for Biological Engineering (SBE), Germany Trade and Invest (GTAI), Bio-Process Systems Alliance (BPSA), European Patent Office (EPO), Pharmaceuticals Export Promotion Council of India (Pharmexcil), India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, and Eurostat, among others. Secondary data was collected and analyzed to arrive at the overall size of the global single use bioreactors market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global single use bioreactors market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as personnel from pharmaceutical and biotechnology companies and academic and research institutes, and purchase managers in healthcare provider organizations) and supply-side (such as C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

single use Bioreactors Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the single use bioreactors market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the single use bioreactors market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive primary and secondary research.
  • The revenues generated from the single use bioreactors products business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Approach 1: Bottom-up approach: Company Revenue Analysis

  • Revenues for individual companies were gathered from public sources and databases.
  • The single-use bioreactors business shares of leading players were gathered from secondary sources to the extent available. In certain cases, the shares of product businesses were ascertained through a detailed analysis of various parameters, including product portfolios and market positioning. 
  • Individual shares or revenue estimates were validated through expert interviews. 

single use Bioreactors Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Approach 2: Secondary Research

  • The size of the single use bioreactors market was obtained from secondary sources.
  • The shares of various single use bioreactors in the overall market were obtained from secondary data and validated through primary participants to arrive at the total single use bioreactors market.
  • Primary participants validated the numbers.

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition:

single use bioreactors (SUBs) or disposable bioreactors are vessels that consist of a disposable bag instead of a typical culture vessel made of stainless steel or glass. SUBs are based on single use technology, which uses disposable equipment to manufacture biopharmaceutical products.  

Key Stakeholders

  • Manufacturers and Distributors of single use Bioreactors and Associated Products
  • Third-party Suppliers
  • Pharmaceutical and Biotechnology Companies
  • Contract Manufacturing Companies (CMOs)
  • Contract Research Organizations (CROs)
  • Market Research and Consulting Firms
  • R&D Centers
  • Medical Institutes and Universities
  • Academic and Research Institutes

Report Objectives

  • To define, describe, segment, and forecast the single use bioreactors market based on product, type, type of cell, type of molecule, application, end user, and region
  • To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall single use bioreactors market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the global single use bioreactors market and comprehensively analyze their core competencies
  • To track and analyze competitive developments, such as product launches, mergers & acquisitions, collaborations, expansions, and partnerships in the single use bioreactors market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Geographical Analysis

  • Further breakdown of the RoE single use bioreactors market, by country
  • Further breakdown of the RoAPAC single use bioreactors market, by country
  • Further breakdown of the RoLA and MEA single use bioreactors markets, by country

Company Information

  • Detailed analysis and profiling of additional market players (Up to five)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 2863
Published ON
Mar, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Single Use Bioreactors Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback